Cargando…
Impact of the Gram-Negative-Selective Inhibitor MAC13243 on In Vitro Simulated Gut Microbiota
New Gram-negative-selective antimicrobials are desirable to avoid perturbations in the gut microbiota leading to antibiotic-induced dysbiosis. We investigated the impact of a prototype drug (MAC13243) interfering with the Gram-negative outer membrane protein LolA on the faecal microbiota. Faecal sus...
Autores principales: | Svanberg Frisinger, Frida, Pirolo, Mattia, Ng, Duncan Y. K., Mao, Xiaotian, Nielsen, Dennis Sandris, Guardabassi, Luca |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9229071/ https://www.ncbi.nlm.nih.gov/pubmed/35745650 http://dx.doi.org/10.3390/ph15060731 |
Ejemplares similares
-
Increasing the permeability of Escherichia coli using MAC13243
por: Muheim, Claudio, et al.
Publicado: (2017) -
In Silico Prediction and Prioritization of Novel Selective Antimicrobial Drug Targets in Escherichia coli
por: Svanberg Frisinger, Frida, et al.
Publicado: (2021) -
LptD depletion disrupts morphological homeostasis and upregulates carbohydrate metabolism in Escherichia coli
por: Frisinger, Frida Svanberg, et al.
Publicado: (2023) -
The porcine respiratory microbiome: recent insights and future challenges
por: Pirolo, Mattia, et al.
Publicado: (2021) -
Repurposing Azithromycin and Rifampicin Against Gram-Negative Pathogens by Combination With Peptidomimetics
por: Baker, Kristin R., et al.
Publicado: (2019)